Full-Time

Senior IT Manager

Operations, 3PL & DC Technology Services

McKesson

McKesson

10,001+ employees

Pharmaceuticals and medical supplies distributor.

Compensation Overview

$99.1k - $132.1k/yr

+ Bonus + Long-Term Incentive

Mississauga, ON, Canada

Hybrid

Two days in office per week; up to 25% travel.

Bachelor's

Category
IT & Security (1)
Required Skills
SAP Products

Get referred to McKesson

See people who can refer or advise you

Requirements
  • Bachelor’s in computer science, Information Technology, Business Administration, or a related field.
  • Minimum 12 years’ experience planning, managing, developing, executing and maintaining SAP WMS/EWM or other ERP solutions in a large-scale, enterprise environment
  • Minimum ten years of SAP or other ERP delivery leadership and end to end implementation experience.
  • Minimum of 10 years’ experience in providing Supply Chain solutions, preferably within an SAP environment utilizing a CoE support model.
  • Minimum of 5 years’ experience as a people manager
  • Proficiency in business process knowledge within distribution space.
  • Experience in managing employees and external vendors & resources.
  • Extensive knowledge of IT governance, operations, and security practices.
  • Demonstrated experience in managing IT services, with a strong understanding of managed service delivery.
  • Proficient in application landscape, including both SAAS and on-premises solutions.
  • Familiarity with ITIL and similar IT service management frameworks, with certifications being a plus.
  • Excellent negotiation, communication, and stakeholder management skills.
  • Ability to manage complex projects and multi-task effectively in a fast-paced environment.
  • Strong background in ERP concepts and functionality in an SAP S/4 HANA environment, including master data management, procurement, order to cash and warehousing
Responsibilities
  • Oversee the management of SAP systems in the order-to-cash, procure-to-pay and warehouse management solutions and all applications integrated with SAP, ensuring they are aligned with business processes and objectives.
  • Ensure successful delivery of supply chain programs/projects using SAP and other tools for multiple business units in the Warehouse Management Systems, Procure-to-Pay and Order-to-Cash areas.
  • Collaborate with the AMS partner to ensure the optimal performance, availability, and stability of supply chain applications like SAP WMS.
  • Oversee the resolution of incidents and problems related to SAP and non-SAP related applications, ensuring minimal business disruption and ensure permanent solutions are put into place for all such critical issues.
  • Build high-performance delivery teams that drive and champion change and stakeholder management.
  • Lead operations, overseeing application reliability, security, and troubleshooting.
  • Govern IT standards for solution delivery ensuring stability and scalability meeting supply chain needs of the business units and ensure standards, processes, and policies are followed to enable integrity and quality of solution delivery
  • Develop stakeholder relationships, share best practices, and ensure communication with IT and business operations
  • Lead the planning and implementation of SAP upgrades, patches and enhancements in coordination with the multiple implementation partners.
  • Serve as the primary point of contact between the organization and the MSP service provider for all matters related to SAP Application Management
  • Monitor the outsourcing partner’s adherence to SLAs and KPIs, particularly those related to SAP and other non-SAP applications and address any service delivery issues.
  • Provide regular review and report results to IT Leadership to ensure they meet evolving business needs and provide inputs for leveraging opportunities for service optimization.
  • Provide strategic guidance on the use of SAP and non-SAP applications to enhance business processes and operational efficiency.
  • Work with internal stakeholders and the MSP partner to identify opportunities for innovation and improvement within the SAP and related non-SAP applications ecosystem.
  • Ensure compliance across all SAP and non-SAP applications related to the service delivery for distribution and customer service business groups.
  • Facilitate regular audits and compliance checks to maintain high standards of governance and control.
  • Lead change management initiatives for SAP and non-SAP related applications, coordinating with the IT and business partners to ensure smooth and effective implementation.
  • Conduct post-implementation reviews to capture learnings and continuously improve the SAP application management process.
  • Develop and support safe and optimal Global DC Operational processes and systems, to eliminate waste and manual efforts across Receiving, Putaway, Picking, and Outbound Logistics functions
  • Support and conduct regular reviews of all DC Operational systems and activities covering methods, procedures, and efficiencies to ensure continuous improvement
  • Report and monitor DC Systems usage and productivity, identifying issues, and trends and providing results to DC Management accordingly
  • Coordinate DC systems/WMS upgrades along with internal and external IT resources
  • Develop and deploy DC system and process SOPs, with regular audits and version control for each SOP
  • Communicate with multiple levels within the organization – from brainstorming with individual business system analysts to discussing actionable strategy with leadership
  • Work with senior leadership to manage demand, capacity, and budgets

McKesson is a global healthcare distributor and services provider. It buys pharmaceuticals and medical products from manufacturers and distributes them to pharmacies, hospitals, and other healthcare facilities, acting as an intermediary in the supply chain. Its core work includes logistics and supply chain management, ensuring medicines and medical supplies reach customers on time and safely. McKesson also offers technology solutions to help healthcare providers manage operations and procurement. Compared with competitors, it leverages a very large-scale network and integrated services—combining distribution, logistics, and technology—across providers, pharmacies, and manufacturers. The company aims to support the healthcare system by keeping essential medical supplies available and helping healthcare facilities run more efficiently, ultimately improving patient care.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Get referred to McKesson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fiscal 2026 revenue hit $403.4 billion, up 12%, with EPS up 18%.
  • Moore's $179 million hub opens automation-driven capacity for Oklahoma and Texas.
  • Board added $5 billion buybacks and raised the dividend to $0.94.

What critics are saying

  • Medical-Surgical separation targets 2027, and Apollo financing increases execution complexity.
  • Opioid settlement overhang keeps legal scrutiny active through 2026 and beyond.
  • GLP-1 revenue concentration ties growth to Novo Nordisk and Eli Lilly pricing.

What makes McKesson unique

  • McKesson moves one-third of North American pharmaceuticals through unmatched distribution scale.
  • PRISM Vision and Core Ventures deepen McKesson's specialty oncology network.
  • Automated hubs like Moore add cold-chain capacity and regional delivery resilience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%
Mining Press Releases
Aug 3rd, 2026
Global Healthcare Fraud Detection Market to reach $9.1 billion by 2030, driven by AI adoption and regulatory pressure.

Global Healthcare Fraud Detection Market to reach $9.1 billion by 2030, driven by AI adoption and regulatory pressure. "According to BCC Research, the global healthcare fraud detection market is projected to grow from $4.4 billion in 2024 to $9.1 billion by 2030, at a CAGR of 12.7%, driven by rising healthcare fraud cases, advances in AI and analytics, expanding cloud-based solutions and increasing adoption across global healthcare systems." Boston, Aug. 03, 2026 (GLOBE NEWSWIRE) - The global healthcare fraud detection market is poised for substantial growth, expanding from $4.4 billion in 2024 to $9.1 billion by 2030, representing a compound annual growth rate of 12.7%, according to a new report from BCC Research titled Global Healthcare Fraud Detection Market. BCC Research is a leading provider of market intelligence and advisory services for emerging technology markets. Key Findings * Market expansion accelerating: The healthcare fraud detection market will more than double over the forecast period, driven by escalating fraud losses and intensifying regulatory enforcement across global healthcare systems * North America dominates: The region commands 46.8% of the global market, reflecting advanced healthcare digitization, stringent regulatory frameworks, and sophisticated fraud detection infrastructure * AI transformation: Accelerated adoption of artificial intelligence, machine learning, and predictive analytics technologies is revolutionizing fraud detection capabilities, enabling real-time monitoring and prevention * Digital infrastructure boom: Widespread implementation of electronic health records and digital claims processing systems is creating vast datasets that power advanced fraud detection algorithms * Emerging market opportunity: Growing digitization of healthcare systems and expansion of insurance coverage in developing markets presents significant growth potential for fraud detection vendors * Competitive landscape consolidation: Established technology leaders including McKesson Corp., IBM Corp., SAS Institute Inc., and Optum Inc. are competing alongside specialized providers like FICO and emerging cloud-native platforms Market Drivers The healthcare fraud detection market is experiencing unprecedented growth driven by the mounting economic impact of healthcare fraud, which costs the industry hundreds of billions annually. Regulatory bodies worldwide are implementing stricter oversight and enforcement mechanisms, compelling healthcare organizations and insurers to invest heavily in sophisticated detection systems. The convergence of artificial intelligence and healthcare digitization is creating a perfect storm for market expansion, as AI-powered systems can analyze vast datasets in real-time to identify suspicious patterns and anomalies that traditional rule-based systems might miss. The shift toward value-based care models and increased transparency requirements are further amplifying demand for comprehensive fraud detection solutions. As healthcare systems become increasingly digital and interconnected, the attack surface for fraudulent activities expands, necessitating more advanced and integrated detection capabilities. Investment Considerations The healthcare fraud detection market presents compelling investment opportunities, particularly for companies developing AI-driven platforms and cloud-based solutions that can scale rapidly across different healthcare ecosystems. The market's defensive characteristics-driven by regulatory compliance rather than discretionary spending-provide resilience during economic downturns. However, investors should consider data privacy regulations and integration complexities as potential headwinds that could slow adoption. Companies with strong partnerships in the healthcare ecosystem and proven regulatory compliance track records, such as Optum and McKesson, appear best positioned to capture market share, while pure-play technology providers like FICO offer more concentrated exposure to the fraud detection opportunity. About the Report The report provides comprehensive market sizing, detailed segmentation analysis, competitive intelligence, and strategic forecasts for the global healthcare fraud detection market through 2030. Global Healthcare Fraud Detection Market includes in-depth analysis of technology trends, regulatory impacts, and investment opportunities across all major geographic regions. About BCC Research BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process. For media inquiries, email [email protected] or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. BCC Research LLC 50 Milk St., Ste. 16, Boston, MA 02109 [email protected] | +1 781-489-7301 www.bccresearch.com Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Yahoo Finance
Jul 25th, 2026
McKesson raises dividend to $0.94 and adds $5B share buyback authorisation

McKesson Corporation announced a quarterly dividend of $0.94 per share, payable on 1 October 2026 to shareholders of record as of 1 September 2026. The healthcare distributor recently increased its share repurchase authorisation by $5 billion, signalling management confidence in the company's earnings power. McKesson's investment case centres on its position as a scale healthcare distributor benefiting from growing drug demand, whilst managing tight margins and regulatory pressure. The company projects $499.3 billion in revenue and $6.1 billion in earnings by 2029, requiring 7.4% annual revenue growth. Simply Wall St community members estimate McKesson's fair value between $827.49 and $2,283.03 per share. The company continues focusing on capital allocation whilst investing in automation and analytics to improve efficiency in the pharmaceutical supply chain.

Home Textiles Today
Jul 23rd, 2026
RH strengthens leadership team with 2 appointments.

RH strengthens leadership team with 2 appointments. Thomas Lester// Retail Editor//July 23, 2026 Corte Madera, Calif. - Upscale home furnishings retailer RH announced a pair of appointments to its senior leadership team. In her new role, Pilon will lead the company's gallery, hospitality, interior design, trade, contract, delight, people and optimization teams across every touchpoint of the Corte Madera, Calif.-based retailer's brand globally. Pilon has been with RH for 18 years and has held key leadership positions across the organization, including field leader of its Northern and Southern California galleries, senior vice president of delight and customer service operations, and most recently served as the company's chief people officer. "Over the past 18 years Sandy has been an important partner and leader of RH's transformation into the leading luxury home brand in the world," said Gary Friedman, chairman and CEO. "Her exceptional leadership and passionate advocacy of our values and beliefs give me great confidence in Sandy's ability to build and lead a team capable of building one of the most admired brands in the world." "I am deeply grateful for the trust Gary and our leadership team have placed in me," Pilon said. "Having spent the last 18 years growing alongside this extraordinary organization, it is an incredible honor to step into this role. I believe the greatest luxury we can offer is an exceptional experience - one that reflects our values in every interaction, inspires our people to do their life's best work, and creates lasting relationships with teams and customers around the world. I couldn't be more excited for what we will build." As chief legal and compliance officer, Hassanein will oversee all areas of the company's legal and compliance functions, including product safety and vendor compliance. He will report to Friedman. Prior to joining RH, Hassanein spent more than 10 years at McKesson Corp., one of the largest healthcare companies in the world, where he was a member of the chief legal officer's leadership team with responsibilities spanning a wide range of areas, including litigation, regulatory, compliance, government relations, supply chain and technology. "We are thrilled to welcome Ryan to Team RH," Friedman said. "Ryan's leadership experience extends well beyond the traditional scope of a legal role based on the range of his contributions at McKesson, one of the largest and most sophisticated companies in the world from a legal and compliance perspective. We believe Ryan is an outstanding addition to our executive leadership team as we continue to optimize our business as part of our growth and international expansion." Added Hassanein, "I am honored to join Gary and Team RH in the quest to build one of the most admired brands in the world and excited to participate in such an extraordinary effort. I look forward to making a meaningful contribution as RH continues to scale its business and strengthen its operational capabilities."

Home Furnishings Business
Jul 23rd, 2026
RH announces new staff promotion & appointment.

RH announces new staff promotion & appointment. RH announced the promotion of Sandy Pilon to Chief Customer Experience & Values Officer, and the appointment of Ryan Hassanein as Chief Legal & Compliance Officer. In her new role, Sandy will lead the Company's Gallery, Hospitality, Interior Design, Trade, Contract, Delight, People and Optimization teams across every touchpoint of the RH Brand globally. Sandy has been a member of Team RH for 18 years and has held key leadership positions across the organization, including Field Leader of its Northern and Southern California Galleries, Senior Vice President of Delight and Customer Service Operations, and most recently served as the Company's Chief People Officer. Gary Friedman, RH chairman and CEO, commented, "Over the past 18 years Sandy has been an important partner and leader of RH's transformation into the leading luxury home brand in the world. Her exceptional leadership and passionate advocacy of our Values and Beliefs give me great confidence in Sandy's ability to build and lead a team capable of building one of the most admired brands in the world." Sandy said, "I am deeply grateful for the trust Gary and our Leadership Team have placed in me. Having spent the last 18 years growing alongside this extraordinary organization, it is an incredible honor to step into this role. I believe the greatest luxury we can offer is an exceptional experience - one that reflects our values in every interaction, inspires our people to do their life's best work, and creates lasting relationships with teams and customers around the world. I couldn't be more excited for what we will build." Ryan Hassanein will oversee all areas of the Company's legal and compliance functions, including product safety and vendor compliance. Prior to joining RH, Mr. Hassanein spent over ten years at McKesson Corporation, one of the largest healthcare companies in the world, where he was a member of the Chief Legal Officer's leadership team with responsibilities spanning a wide range of areas, including litigation, regulatory, compliance, government relations, supply chain and technology. Mr. Hassanein will report to RH Chairman and Chief Executive Officer Gary Friedman and serve as a member of the Company's Executive Leadership Team. Friedman commented, "We are thrilled to welcome Ryan to Team RH. Ryan's leadership experience extends well beyond the traditional scope of a legal role based on the range of his contributions at McKesson, one of the largest and most sophisticated companies in the world from a legal and compliance perspective. We believe Ryan is an outstanding addition to our Executive Leadership Team as we continue to optimize our business as part of our growth and international expansion." Mr. Hassanein said, "I am honored to join Gary and Team RH in the quest to build one of the most admired brands in the world and excited to participate in such an extraordinary effort. I look forward to making a meaningful contribution as RH continues to scale its business and strengthen its operational capabilities."

Yahoo Finance
Jul 22nd, 2026
McKesson delivers 18% earnings growth as FY26 revenues hit $403B

McKesson Corporation, the leading pharmaceutical distributor in North America, has demonstrated strong financial performance. In fiscal 2026, revenues reached $403.4 billion, up 12% from the previous year, whilst adjusted earnings per share rose 18% year-over-year to $39.11. The company operates through four segments, with North American Pharmaceutical generating $336.7 billion in revenue. Specialty pharmaceuticals and GLP-1 medications for diabetes and obesity are key growth drivers, with GLP-1 revenues alone reaching nearly $41 billion in FY25. McKesson is streamlining operations by selling its Canadian business, exiting Norway, and planning to spin off its Medical-Surgical unit. Simultaneously, it's expanding its US Oncology Network through acquisitions of PRISM Vision and Core Ventures, aiming to increase exposure to higher-margin specialty and oncology services.